Human Genome Epidemiology Literature Finder
|
Records 1 - 11 (of 11 Records) |
| Query Trace: Disease Progression and Mos[original query] |
|---|
| Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy. BMC cancer 2017 Jun 17 (1): 451. Karageorgopoulou Sofia, Kostakis Ioannis D, Gazouli Maria, Markaki Sonia, Papadimitriou Marios, Bournakis Evangelos, Dimopoulos Meletios-Athanassios, Papadimitriou Christos |
| Clinical implication of tumor mutational burden in patients with HER2-positive refractory metastatic breast cancer. Oncoimmunology 2018 7 (8): e1466768. Park Song Ee, Park Kyunghee, Lee Eunjin, Kim Ji-Yeon, Ahn Jin Seok, Im Young-Hyuck, Lee Choonghoon, Jung Hun, Cho Soo Youn, Park Woong-Yang, Cristescu Razvan, Park Yeon H |
| Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study. Journal of translational medicine 2019 2 17 (1): 52. Wang Wenxian, Wang Hong, Lu Peihua, Yu Zongyang, Xu Chunwei, Zhuang Wu, Song Zheng |
| Apatinib Monotherapy or Combination Therapy for Non-Small Cell Lung Cancer Patients With Brain Metastases. Oncology research 2019 Oct . Xu Jianping, Liu Xiaoyan, Yang Sheng, Shi Yuank |
| Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial. JAMA oncology 2021 Aug . Martinelli Erika, Martini Giulia, Famiglietti Vincenzo, Troiani Teresa, Napolitano Stefania, Pietrantonio Filippo, Ciardiello Davide, Terminiello Marinella, Borrelli Carola, Vitiello Pietro Paolo, De Braud Filippo, Morano Federica, Avallone Antonio, Normanno Nicola, Nappi Anna, Maiello Evaristo, Latiano Tiziana, Falcone Alfredo, Cremolini Chiara, Rossini Daniele, Santabarbara Giuseppe, Pinto Carmine, Santini Daniele, Cardone Claudia, Zanaletti Nicoletta, Di Liello Alessandra, Renato Daniela, Esposito Lucia, Marrone Francesca, Ciardiello Fortuna |
| Front-Line ICI-Based Combination Therapy Post-TKI Resistance May Improve Survival in NSCLC Patients With EGFR Mutation. Frontiers in oncology 2021 12 11 739090. Tian Tian, Yu Min, Li Juan, Jiang Maoqiong, Ma Daiyuan, Tang Shubin, Lin Zhiyu, Chen Lin, Gong Youling, Zhu Jiang, Zhou Qiang, Huang Meijuan, Lu Y |
| Safety and efficacy of nivolumab plus recombinant human endostatin in previously treated advanced non-small-cell lung cancer. Translational lung cancer research 2022 3 11 (2): 201-212. Lv Weize, Pei Xiaofeng, Zhao Wenhua, Cong Yunyan, Wei Yajun, Li Ting, Zhang Hongyu, Lin Zhong, Saito Yuichi, Kim Jae Jun, Liang Zibin, Zhong Beilong, Wang Zhih |
| Therapeutic Outcomes and Prognostic Impact of Gene Mutations Including TP53 and SF3B1 in Patients with Del(5q) Myelodysplastic Syndromes (MDS). Clinical lymphoma, myeloma & leukemia 2022 2 22 (7): e467-e476. Chan Onyee, Ali Najla Al, Sallman David, Padron Eric, Lancet Jeffrey, Komrokji Ra |
| The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study. Cancer medicine 2022 11 . Yu Xiaoqing, Si Jinfei, Wei Jingwen, Wang Yanling, Sun Yan, Jin Jianan, Zhang Xiaoyan, Ma Tonghui, Song Zheng |
| Large-Scale, Multicenter, Prospective Registry Study of Ripretinib in Advanced GIST: A Real-World Study from China. Advances in therapy 2023 6 . Xinhua Zhang, Peng Zhang, Haibo Qiu, Yong Fang, Heli Liu, Yongjian Zhou, Hao Xu, JiRen Yu, Jun Zhang, Ming Wang, Lin Shen, Jian |
| Osimertinib combined with bevacizumab as the first-line treatment in non-small cell lung cancer patients with brain metastasis harboring epidermal growth factor receptor mutations. Thoracic cancer 2023 4 . Zhang Ling, You Yunhong, Liu Xueli, Liu Fengjuan, Nie Keke, Ji Youx |
- Page last reviewed:Feb 1, 2024
- Content source: